Donate For Public and Patients Store Search

U085 - Plan B for the Dermatologic Surgeon: Management of Misbehaving Tumors

Monday, March 4; 4:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify clinical scenarios where additional management following mohs surgery is needed.
  • Describe treatment options for recurring tumors or deeply infiltrating tumors.
  • Review multidisciplinary approach in managing challenging tumors.

Description

Mohs micrographic surgeons are sometimes faced with clinical cases that present unique challenges. At the conclusion of this session, dermatologic/Mohs surgeons should be able to: 1) Identify clinical scenarios where additional management following surgery is needed; 2) Describe treatment options for recurring tumors or deeply infiltrating tumors; and 3) Review the multidisciplinary approach often needed in managing challenging tumors.

Disclosures

  • Krunic, Aleksandar L. J., MD, PhD: no financial relationships exist with commercial interests.
  • Somani, Ally-Khan, MD, PhD: Aviragen Therapeutics Inc. – C(Fees); Castle Biosciences, Inc – I(Grants/Research Funding); Cook Biotech Inc. – A(Fees);
  • Zeitouni, Nathalie C., MD: Biofrontera AG – A(H), I(Grants/Research Funding); Genentech, Inc. – SP(H); MiMedx Group, Inc – C(H); Sanofi/Regeneron – A(H), SP(H); Solgenix, Inc. – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – A(H), I(Grants/Research Funding);
Schedule
Monday, March 4
4:30 PM
Dr. Somani / Introduction - Plan B for the Dermatologic Surgeon: Management of Misbehaving Tumors
4:35 PM
Dr. Zeitouni / Surgical Cases
4:50 PM
Dr. Krunic / Surgical Cases
5:05 PM
Dr. Somani / Surgical Cases
5:20 PM
All faculty / Panel Q&A
Event Details
  • Date
    Monday, March 4
  • Time
    4:30 PM - 5:30 PM
  • Location
    Room 101
  • CME Credits
    1.00
  • Type
Directors/Co-Directors
  • Ally-Khan Somani, MD, PhD, FAAD
Speakers
  • Aleksandar L. J. Krunic, MD, PhD, FAAD
  • Nathalie C. Zeitouni, MD, FAAD